Andere Sprachen RetinalGenix Technologies Inc.

Aktien

RTGN

US76133Y1055

RTGN

Markt geschlossen - OTC Markets Andere Börsenplätze 18:47:02 22.02.2024			% 5 Tage	% 1. Jan.
3.5 ^USD	+12.90%		-.--%	+13.27%

01.04.	RetinalGenix Technologies Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	RetinalGeniX? Technologies Inc. schließt einen Vertrag mit Medsan, Inc. über die Bereitstellung von diagnostischen Tests für das Institutional Review Board zur Durchführung einer Studie zur Personalisierung der medizinischen Bewertung von Patienten, die eine Behandlung für feuchte Makuladegeneration erhalten	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

IN DIRETTA DAI MERCATI: Amplifon, Aena, Generali, Nexi, Stellantis, Terna, Zignago Vetro, Novo Nordisk, Pandora, ING, eBay...	02.05.
RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy	22.02.
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy	22.02.
RetinalGenix Technologies Inc. announced that it has received $4.65 million in funding	09.02.
RetinalGenix Technologies Inc. announced that it expects to receive $4.65 million in funding	23.01.
RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration	26.12.
RetinalGeniX?? Technologies Inc. Contracts with Medsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration	26.12.
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board	21.12.
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board	21.12.
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Medical Advisory Board	21.12.
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors	04.12.
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors	04.12.
RetinalGeniX Technologies Inc. Appoints Dessislava Boneva to its Board of Directors	04.12.
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO	01.12.
RetinalGenix Technologies Inc. Appoints Virender Ahluwalia as Interim Chief Financial Officer	01.12.
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board	28.11.
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board	28.11.
RetinalGenix Technologies Inc. Appoints Stephen Tannenbaum to the Business Advisory Board	28.11.
RetinalGenix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen RetinalGenix Technologies Inc.

Aktien

RTGN

US76133Y1055

RTGN

Andere Sprachen

Filter